327 related articles for article (PubMed ID: 19204190)
21. High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand.
Tongtawee T; Dechsukhum C; Matrakool L; Panpimanmas S; Loyd RA; Kaewpitoon SJ; Kaewpitoon N
Asian Pac J Cancer Prev; 2015; 16(18):8281-5. PubMed ID: 26745073
[TBL] [Abstract][Full Text] [Related]
22. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.
Koga T; Inoue H; Ishii C; Okazaki Y; Domon H; Utsui Y
J Antimicrob Chemother; 2002 Jul; 50(1):133-6. PubMed ID: 12096020
[TBL] [Abstract][Full Text] [Related]
23. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K
J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301
[TBL] [Abstract][Full Text] [Related]
24. Histological changes in refractory Helicobacter pylori infection and its relationship with increased levels of resistance to antibiotics and therapeutic regimens: one-year follow-up.
Bayati S; Alebouyeh M; Amirmozafari N; Ebrahimi Daryani N; Talebi M; Zali MR
APMIS; 2020 Jan; 128(1):25-34. PubMed ID: 31628820
[TBL] [Abstract][Full Text] [Related]
25. Epinecidin-1 antimicrobial activity: In vitro membrane lysis and In vivo efficacy against Helicobacter pylori infection in a mouse model.
Narayana JL; Huang HN; Wu CJ; Chen JY
Biomaterials; 2015 Aug; 61():41-51. PubMed ID: 25996410
[TBL] [Abstract][Full Text] [Related]
26. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
27. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation.
Thamphiwatana S; Gao W; Obonyo M; Zhang L
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17600-5. PubMed ID: 25422427
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial activities of peptide Cbf-K
Jiang M; Ma L; Huang Y; Wu H; Dou J; Zhou C
Microb Pathog; 2020 Jan; 138():103847. PubMed ID: 31704464
[TBL] [Abstract][Full Text] [Related]
29. Anti-Inflammatory Effects of Capsaicin and Piperine on Helicobacter pylori-Induced Chronic Gastritis in Mongolian Gerbils.
Toyoda T; Shi L; Takasu S; Cho YM; Kiriyama Y; Nishikawa A; Ogawa K; Tatematsu M; Tsukamoto T
Helicobacter; 2016 Apr; 21(2):131-42. PubMed ID: 26140520
[TBL] [Abstract][Full Text] [Related]
30. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
[TBL] [Abstract][Full Text] [Related]
31. Turmeric and curcumin as adjuncts in controlling Helicobacter pylori-associated diseases: a narrative review.
Boyanova L; Medeiros J; Yordanov D; Gergova R; Markovska R
Lett Appl Microbiol; 2024 Jun; 77(6):. PubMed ID: 38794899
[TBL] [Abstract][Full Text] [Related]
32. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori.
Shirin H; Moss SF; Kancherla S; Kancherla K; Holt PR; Weinstein IB; Sordillo EM
J Gastroenterol Hepatol; 2006 Sep; 21(9):1388-93. PubMed ID: 16911681
[TBL] [Abstract][Full Text] [Related]
33. In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori.
Koga T; Kawada H; Utsui Y; Domon H; Ishii C; Yasuda H
J Antimicrob Chemother; 1996 May; 37(5):919-29. PubMed ID: 8737142
[TBL] [Abstract][Full Text] [Related]
34. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells.
Foryst-Ludwig A; Neumann M; Schneider-Brachert W; Naumann M
Biochem Biophys Res Commun; 2004 Apr; 316(4):1065-72. PubMed ID: 15044093
[TBL] [Abstract][Full Text] [Related]
35. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications.
Gerrits MM; van Vliet AH; Kuipers EJ; Kusters JG
Lancet Infect Dis; 2006 Nov; 6(11):699-709. PubMed ID: 17067919
[TBL] [Abstract][Full Text] [Related]
37. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen.
Mahady GB; Pendland SL; Yun G; Lu ZZ
Anticancer Res; 2002; 22(6C):4179-81. PubMed ID: 12553052
[TBL] [Abstract][Full Text] [Related]
38. Treatment of Helicobacter pylori infected mice with Bryophyllum pinnatum, a medicinal plant with antioxidant and antimicrobial properties, reduces bacterial load.
Kouitcheu Mabeku LB; Eyoum Bille B; Tchouangueu TF; Nguepi E; Leundji H
Pharm Biol; 2017 Dec; 55(1):603-610. PubMed ID: 27937097
[TBL] [Abstract][Full Text] [Related]
39. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
[TBL] [Abstract][Full Text] [Related]
40. [Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Kim JY; Kim N; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Nam RH; Kim JM; Lee JH; Jung HC; Song IS
Korean J Gastroenterol; 2011 Dec; 58(2):74-81. PubMed ID: 21873821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
